Login to Your Account

ASH 2011

Targeting Tumors' Blood Supply Can, Should Move Beyond VEGF

By Anette Breindl
Science Editor

Thursday, December 15, 2011

SAN DIEGO – Broadening the repertoire of anti-angiogenesis approaches might allow the method to be used in more cancer types, and more successfully in cancer types where it's already used.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription